Stada’s ViruProtect Could Prevent COVID Infection, In Vitro Study Shows
A recent in vitro study shows that Enzymatica's ColdZyme throat spray – the basis for Stada's ViruProtect in Belgium and Austria – could offer a protective barrier against harmful viruses such as SARS-CoV-2.
You may also be interested in...
New German wellness launches: Immunity boosting food supplements from Stada, Pascoe, Dr Scheffler, Queisser and Infecto.
HBW Insight speaks exclusively to Chris Morrey, CEO of Stada's UK Nature's Aid subsidiary, about the company's experiments with CBD and its recently submitted EU novel food application.
Stada CEO Peter Goldschmidt tells HBW Insight about his ambition to enter the US consumer health market as part of a push to take the business global.